News Medical on MSN18h
Low-dose semaglutide reduces alcohol consumption and cravings in early trial
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
BioSpace19h
Novo’s Semaglutide Shows Promise for Alcohol Use Disorder
The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...
Neuroscience News1d
Semaglutide Shows Promise in Reducing Alcohol Cravings and Consumption
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.
New Atlas1d
Ozempic dials down alcohol cravings for people wanting to cut back
In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...
Groundbreaking trial discovers Ozempic could be used to tackle alcoholism epidemic
A groundbreaking clinical trial has revealed that weight-loss injections marketed as Ozempic and Wegovy may significantly ...
Science Media Centre1d
expert reaction to study looking at once-weekly semaglutide in adults with alcohol use disorder
‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...
Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC
Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...